Tennessee lawmakers move to control cannabis rescheduling

Tennessee Lawmakers Move to Centralize Control Over Cannabis Rescheduling Decisions in State Hands

What began as a proposal to study the feasibility of a medical cannabis program in Tennessee has evolved into legislation that would significantly limit the authority of state health officials over cannabis rescheduling decisions, shifting final control to the General Assembly.

On April 13, the Tennessee House voted 73–22 to send Gov. Bill Lee legislation that includes a controversial amendment requiring legislative approval before state agencies can change cannabis’s controlled substance status in response to federal action.

The bill, Senate Bill 1603, now moves forward with provisions that effectively block automatic alignment between state and federal cannabis scheduling changes unless lawmakers explicitly authorize it.

Legislation Would Restrict State Health Commissioners From Acting on Federal Cannabis Rescheduling Changes Without Legislative Approval

Under current Tennessee law, state health commissioners have the authority to “similarly control” substances when they are rescheduled or removed from the federal controlled substances list.

However, the amended bill would require the General Assembly to first establish a regulatory framework for cannabis and then specifically authorize any rescheduling actions by state agencies.

This means that even if cannabis were reclassified at the federal level, Tennessee agencies could not independently update state scheduling without legislative approval.

Rep. Andrew Farmer (R-Sevierville), who sponsored the House version of the bill, said the amendment ensures that lawmakers retain control over any future cannabis policy decisions.

“So if the federal government were to reschedule medical cannabis from Schedule I to Schedule III,” Farmer said, “before any department or agency could do anything with it, they would have to have legislation from this body.”

Tennessee’s Cannabis Policy Debate Intensifies as Federal Rescheduling Looms on the Horizon

The legislative push comes as federal discussions continue around potentially rescheduling cannabis from Schedule I to Schedule III following a December executive order issued by President Donald Trump directing expedited review.

Lawmakers backing the Tennessee measure argue that the state should not automatically follow federal changes without first building its own regulatory system.

Sen. Todd Gardenhire (R-Chattanooga) introduced the amendment in the Senate, where it passed 21–12 on March 26 before advancing to the House.

Supporters of the measure say it is intended to ensure deliberate policymaking rather than reactive regulatory shifts driven by federal decisions.

Critics Warn Tennessee Risks Further Delay After Years of Legislative Inaction on Medical Cannabis Reform

Opponents of the amendment argue that it risks locking Tennessee into continued inaction on cannabis reform.

Sen. Kerry Roberts (R-Springfield) pointed to the state’s long-standing failure to establish a medical cannabis program, noting that Tennessee remains one of only eight states without one.

“We haven’t done anything for years,” Roberts said, warning that requiring legislative approval could prevent timely action even if federal rescheduling occurs.

Roberts, who has served in the Senate since 2015, contrasted Tennessee’s approach with neighboring states such as Kentucky, Alabama, Mississippi, and Georgia, all of which have adopted varying forms of medical cannabis programs or low-THC systems.

Debate Highlights Diverging Views Over Whether State Control Prevents Chaos or Delays Reform

During Senate debate, Sen. Ferrell Haile (R-Gallatin), the bill’s sponsor, defended the amendment by arguing that cannabis policy should not be left to administrative agencies alone.

“We don’t want the Wild West out here,” Haile said, adding that the General Assembly must remain the primary decision-maker on such a significant policy shift.

Sen. Heidi Campbell (D-Nashville) pushed back, arguing that Tennessee already struggles with an unregulated cannabis-like market, particularly in intoxicating hemp products that have proliferated in recent years.

Campbell said stronger regulation—not delayed legislative control—was needed, pointing to concerns that consumers currently lack reliable product standards and that unregulated markets are fueling illicit activity.

Medical Cannabis Study Provision Remains in Bill as Lawmakers Signal Future Review Process

Despite the controversy over rescheduling authority, the bill still includes a provision directing the Tennessee Advisory Commission on Intergovernmental Relations (TACIR) to study the potential creation of a medical cannabis program.

The study must evaluate implementation pathways and assess the readiness of state and local governments to administer a regulated cannabis system. TACIR is required to submit its findings to the General Assembly by November 1 if the bill is signed into law.

Sen. Haile also referenced separate, more comprehensive cannabis legislation currently under consideration, describing it as a complex 99-page proposal that is unlikely to advance before the end of the legislative session.

He said discussions over medical cannabis policy will continue through a planned summer study process, emphasizing that the issue remains unresolved but under active review.